• Skip to main content
  • Skip to footer

Pachyonychia Congenita Project

Fighting for a cure. Connecting & helping patients. Empowering Research.

Donate
VIEW MENUMENU
  • Pachyonychia Congenita
        • What Is Pachyonychia Congenita?
          • Could I Have PC?
          • Getting Diagnosed
          • Genetics
          • Image Library
          • Glossary
          • Brochures
          • Patient Stories
        • Patient Registry (IPCRR)
          • Patient Registry Data
        • Understanding my Genetic Testing Results
          • K6a-pEDD-PC
          • K6b-pEDD-PC
          • K6c-pEDD-PC
          • K16-pEDD-PC
          • K17-pEDD-PC
          • Non-PC Palmoplantar EDDs
        • Managing and Caring For PC
          • Tips and Tools
          • Living With PC
          • PC & Children
          • Working With Medical Professionals
          • Family & Friends: How To Help
          • Video Library
  • For Professionals
        • For Professionals
          • International PC Consortium
          • Pharmaceutical Partners
          • Refer a Patient
          • Patient Registry (IPCRR)
            • Patient Registry Data
            • Non-PC Palmoplantar EDDs
          • Advocacy Partners
        • PC Research
          • Apply for a Grant
          • Awarded Grants
          • Published Research Articles
          • Clinical Trials
        • Patient Voices
          • Quality of Life
          • Patient Stories
          • Patient-Focused Drug Development Meeting
  • Ways To Give
        • Ways You Can Give
          • Donate
          • Donate Just Giving UK
          • Steady Relief Circle
          • Donor-Advised Fund
          • Giving Stock
          • Legacy Society
        • Raise Awareness
          • How You Can Help
          • Fundraising Ideas
          • Share Your Story
          • PC Advocates
          • Volunteer
        • 2025 Donor Gratitude Wall
  • News & Events
        • News
          • Current Newsletter
          • Newsletter Archives
          • Sign up for our Newsletter
        • Events
          • Patient Support Meetings
          • IPCC Meetings
          • Video Library
  • About Us
        • About PC Project
        • Medical and Scientific Advisory Board
        • Financial & Legal Information
        • Contact Us

GJB6-pEDD (palmoplantar Epidermal Differentiation Disorder)

Commonly referred to as “Clouston Syndrome” or Connexin 30

Facts

  • What does GJB6 stand for? Gap junction beta 6 gene.1
  • What does the GJB6 gene do? Encodes the gap junction protein connexin 30.1
  • What happens when GJB6 becomes mutated? Hair loss, nail changes, and thickened skin of the palms and soles.1
  • Clinical significance of mutation? Cellular hyperproliferation & hyperkeratotic lesions along with other traits in most phenotypes.1

About GJB6-pEDD or Clouston syndrome

Skin disease caused by GJB6 mutations is known as hidrotic ectodermal dysplasia (HED) or Clouston syndrome.1 Clouston syndrome is a rare, genetic disease that is found among families worldwide and occurs in approximately 1 per 500,000 live births.3,4 The disease is passed down from a parent to their offspring in an autosomal dominant inheritance pattern.1 This means that it only takes one copy of the mutated GJB6 gene from one parent to cause Clouston syndrome. The parent who has Clouston syndrome has a 50% chance of passing the mutated GJB6 gene in each pregnancy. A diagnosis of Clouston syndrome is sometimes delayed due to milder symptoms in young patients as well as a wide variety of phenotypes among patients with the disease.1 There have also been several families that have Clouston syndrome, but were previously diagnosed with pachyonychia congenita. For these reasons, genetic testing is emphasized and necessary to determine whether an individual with symptoms of Clouston syndrome is caused by a mutation in the GJB6 gene.2

Symptoms of GJB6

Major features of Clouston syndrome include hair loss, nail abnormalities, and palmoplantar hyperkeratosis.  Nail dystrophy and sparse hair are typically noted during early infancy, while palmoplantar keratosis presents in childhood.4 The hair loss among affected individuals ranges from partial to complete hair loss. Additionally, individuals may have sparse, short, or absent eyebrows and eyelashes.1 Individuals with Clouston syndrome that have nail dystrophy typically have nails that are thickened, ridged, and hyperconvex.1 Palmoplantar keratosis is a term used to describe thickening of the skin on the palms of the hands and soles of the feet. The severity of palmoplantar keratosis varies among individuals with Clouston syndrome and tends to increase with age.1,4


IPCRR Data for GJB6


Thirty two individuals fully enrolled in the International Pachyonychia Congenita Research Registry (IPCRR) were found not to have PC but instead carry a mutation in GJB6 gene. Sixteen are in the United States, and five are in the Netherlands. The rest of the families and individuals are located in Poland, Sweden, Australia, Croatia, Brazil, the UK, India, and Canada. Fourteen are females and eighteen are males. Below is select data from the registry.

Plantar Keratoderma56%
Always (never goes away)47%
Sometimes (clears up at times)9%
Seldom (feet usually clear)0%
Plantar Keratoderma – Onset
Birth or less than 1 year11%
1 to 4 years old28%
5 to 14 years old44%
15 years and over17%
Plantar Pain50%
Often require medications for pain9%
Very painful, but do not use medications13%
Somewhat painful13%
Palmar Keratoderma50%
Always (never goes away)31%
Sometimes (clears up at times)9%
Seldom (hands usually clear)9%

Toenail Dystrophy63%
all 10 toenails thickened47%
7-9 toenails thickened9%
4-6 toenails thickened3%
1-3 toenails thickened3%
Toenails – Onset
Birth or less than 1 year70%
1 to 4 years old25%
5 to 14 years old5%
15 years and over0%
Fingernail Dystrophy63%
all 10 fingernails thickened56%
7-9 fingernails thickened0%
4-6 fingernails thickened3%
1-3 fingernails thickened3%
Fingernails – Onset
Birth or less than 1 year70%
1 to 4 years old25%
5 to 14 years old5%
15 years and over0%
Oral Leukokeratosis13%
Cysts0%
Follicular Hyperkeratosis0%
Natal or Prenatal Teeth0%

Data from 2022 Sample Size N=32

References

  1. Cammarata-Scalisi F, Rinelli M, Pisaneschi E, et al. Novel clinical features associated with Clouston syndrome. Int J Dermatol. 2019;58(8):e143-e146. doi:10.1111/ijd.14507
  2. Hu YH, Lin YC, Hwu WL, Lee YM. Pincer nail deformity as the main manifestation of Clouston syndrome. Br J Dermatol. 2015;173(2):581-583. doi:10.1111/bjd.13703
  3. Lamartine, J., Munhoz Essenfelder, G., Kibar, Z. et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet 26, 142–144 (2000). https://doi.org/10.1038/79851
  4. Leung, A. K., Leong, K. F., & Lam, J. M. (2021). Clouston syndrome. Consultant, 61(1), 29-31.

Above photos are from individuals in the IPCRR with confirmed GJB6 mutations.

Other Conditions With Painful PPK

Footer

PC Project logo in white
PACHYONYCHIA CONGENITA PROJECT

P.O. Box 17850
Holladay, UT 84117

info@pachyonychia.org

801-987-8758

EIN 68-0567493

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Sign up for our Newsletter

Loading

Support PC Project

There are many ways you can help improve the lives of those who suffer from Pachyonychia Congenita.

Learn More
  • Contact Us
  • About Us
  • Donate
  • Patient Registry

Copyright © 2026 PC Project. All rights reserved. Pachyonychia Congenita Project is a 501(c)(3) under federal tax guidelines. Using this site means you accept its terms as outlined in the disclaimer and privacy policy.